No abstract

Mycotoxins often contaminate cattle food, which can cause liver damage, immunosuppression, and reduced milk production. Although previous studies have shown the benefits of adsorbents in farm animals, knowledge regarding their mechanism of action is limited, especially when intoxication occurs due to naturally contaminated diets. The present study aimed to assess whether the daily oral administration of mycotoxin adsorbent bentonite clay based on aluminosilicate for 56 days, would attenuate these changes in 18 dairy cows, which were multiparous in the middle of the lactation stage, and were consuming a diet containing fumonisin B1 and B2, zearalenone, and desoxynivalenol. The animals were divided into treatment (TG, n = 9) and control (CG, n = 9) groups, and subjected to assessment of liver functions, hematological assessments, assessment of oxidative leucocyte metabolism by the tetrazolium nitroazul (NBT) technique, and physical chemical analysis of milk, every week for two months, totaling eight analyses. It was observed that the use of the adsorbent caused a reduction in the milk excretion of aflatoxin M1 (AFM1), an increase in levels of serum protein (p = 0.03) and albumin (p = 0.0001), an increase in leukocyte oxidative metabolism from day 24 of treatment(p = 0.05), and increased milk production from the day 16 of treatment (p = 0.08). There was no improvement in the physicochemical indices of the milk. It was concluded that the use of an aluminosilicate-based adsorbent was able to attenuate the effects of mycotoxins on the function of leukocytes and increase milk production.

As mycotoxins are consistent contaminants in the dairy cow diet, the use of adsorbents is recommended, although there are no ideal adsorbents. Although there are studies on this subject, few have focused on chronic natural intoxications. Here, we evaluated the effect of bentonite adsorbents associated with liver antioxidants on the health and milk production of dairy cows fed a diet containing naturally-produced fumonisin, zearalenone, and deoxynivalenol. Eighteen dairy cows (bodyweight 550 ±50 kg, 5 ± 2 years old, and 30 ± 1,25 kg/day milk production) in the middle of lactation were divided into groups: treatment (TG, n = 9, 22 g/day of supplement added to diet) and control (CG, n = 9, without supplement). A physical examination was performed, weekly over 56 days and blood was collected for liver and immune assessments. Milk was harvested to evaluate milk production and content (fat protein, somatic cell count, and lactose). The additive promoted beneficial effects on the liver from the 24th day due to a decrease in the enzymatic activities of gamma-glutamyltransferase and lactate dehydrogenase and increased serum protein and albumin levels. There were improvements in health, evidenced as fewer clinical manifestations of the disease, greater leukocyte oxidative metabolism capacity, and a lower neutrophil lymphocytes ratio. The treatment also promoted a 19% increase in milk volume. It was concluded that the additive promoted health benefits and milk production in dairy cows.